Get the Stockscreener App
18.47
1.21%
0.22
After Hours:
18.32
-0.15
-0.81%
Terns Pharmaceuticals Inc stock is traded at $18.47, with a volume of 3.46M.
It is up +1.21% in the last 24 hours and up +131.16% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$18.25
Open:
$18
24h Volume:
3.46M
Relative Volume:
1.65
Market Cap:
$1.62B
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-13.99
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+123.61%
1M Performance:
+131.16%
6M Performance:
+510.58%
1Y Performance:
+161.61%
1-Day Range:
$17.39
$18.50
1-Week Range:
$12.77
$18.75
52-Week Range:
$1.865
$18.75
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
18.47 | 1.60B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Nov-03-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Oct-15-25 | Initiated | Truist | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-04-25 | Resumed | H.C. Wainwright | Neutral |
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
What does recent volatility data suggest for Terns Pharmaceuticals Inc.July 2025 Institutional & Verified Swing Trading Watchlist - newser.com
How hedge fund analytics apply to Terns Pharmaceuticals Inc. stockPortfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Relative strength of Terns Pharmaceuticals Inc. in sector analysisOptions Play & Free Growth Oriented Trading Recommendations - newser.com
Combining price and volume data for Terns Pharmaceuticals Inc.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Real time breakdown of Terns Pharmaceuticals Inc. stock performanceMarket Trend Report & Reliable Price Breakout Alerts - newser.com
How sentiment analysis helps forecast Terns Pharmaceuticals Inc.Product Launch & Real-Time Chart Pattern Alerts - newser.com
Is Terns Pharmaceuticals Inc. stock a top momentum playPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Day 7 of Gains Streak for Terns Pharmaceuticals Stock with 126% Return (vs. 233% YTD) [11/7/2025] - Trefis
Biotech Deals And Breakthroughs Spark Heavy Trading Across Markets - Finimize
Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Analyst Upgrade & Proven Capital Preservation Methods - newser.com
Applying Wyckoff theory to Terns Pharmaceuticals Inc. stockEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Is Terns Pharmaceuticals Inc. still worth holding after the dip2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Will Terns Pharmaceuticals Inc. stock recover faster than market2025 Momentum Check & Verified Short-Term Plans - Fundação Cultural do Pará
Should you hold or exit Terns Pharmaceuticals Inc. nowJuly 2025 Action & Weekly Breakout Watchlists - newser.com
Will Terns Pharmaceuticals Inc. stock recover after recent drop2025 Key Highlights & Technical Pattern Based Signals - newser.com
Day 5 of Gains Streak for Terns Pharmaceuticals Stock with 127% Return (vs. 228% YTD) [11/5/2025] - Trefis
Price momentum metrics for Terns Pharmaceuticals Inc. explainedJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Terns Pharmaceuticals (TERN): Assessing Valuation Following Promising TERN-701 CML Trial Results and Analyst Upgrades - Yahoo Finance
Sector ETF performance correlation with Terns Pharmaceuticals Inc.Analyst Downgrade & Community Verified Watchlist Alerts - newser.com
Is Terns Pharmaceuticals Inc. stock resilient to inflationJuly 2025 EndofMonth & Breakout Confirmation Trade Signals - Fundação Cultural do Pará
Terns Pharmaceuticals director sells $441k in stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals director sells $441k in stock - Investing.com
TERN Crosses Above Average Analyst Target - Nasdaq
Terns Pharmaceuticals announces data from CARDINAL trial of TERN-701 - MSN
Terns Pharmaceuticals stock price target raised to $22 at BMO on strong ASH data - Investing.com Canada
BMO Capital Maintains Terns Pharmaceuticals (TERN) Outperform Recommendation - Nasdaq
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals stock hits 52-week high at 16.41 USD By Investing.com - Investing.com Canada
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday - Benzinga
Terns Pharma (TERN) Receives Price Target Raise to $28 by Truist - GuruFocus
Truist Financial Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Announces Target Price $28 - 富途牛牛
Terns Pharmaceuticals stock extends gain after positive CML drug data By Investing.com - Investing.com Canada
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Terns Pharmaceuticals Inc Stock (TERN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Quigley Jill M. | Director |
Nov 04 '25 |
Sale |
18.00 |
24,520 |
441,360 |
0 |
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):